These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10347937)

  • 1. [Efficacy and tolerance of the bisoprolol/hydrochlorothiazide combination in arterial hypertension].
    Luna RL; Oigman W; Ramirez JA; Mion D; Batlouni M; da Rocha JC; Feitosa GS; Castro I; Chaves Júnior Hde C; God EM; Maia LN; Ortega KC; Raineri AM
    Arq Bras Cardiol; 1998 Oct; 71(4):601-8. PubMed ID: 10347937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.
    Frishman WH; Bryzinski BS; Coulson LR; DeQuattro VL; Vlachakis ND; Mroczek WJ; Dukart G; Goldberg JD; Alemayehu D; Koury K
    Arch Intern Med; 1994 Jul; 154(13):1461-8. PubMed ID: 8018001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study between bisoprolol and metoprolol, combined with hydrochlorothiazide, as antihypertensive therapy].
    Unzueta Montoya A; Unzueta A; Ordóñez Toquero G; Villasis Keever MA; Cocoletzi López J; Medina Santillán R
    Arch Inst Cardiol Mex; 2000; 70(6):589-95. PubMed ID: 11255718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension.
    Lewin AJ; Lueg MC; Targum S; Cardenas P
    Clin Cardiol; 1993 Oct; 16(10):732-6. PubMed ID: 8222387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose bisoprolol/hydrochlorothiazide: an option in first-line, antihypertensive treatment.
    Zachariah PK; Messerli FH; Mroczek W
    Clin Ther; 1993; 15(5):779-87. PubMed ID: 8269444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical efficiency and safety of bisoprolol hydrochlorothiazide in patients with mild to moderate essential hypertension].
    Jiang H; Ke YN;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):605-8. PubMed ID: 17081362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
    Jayaram S; Lahoti S; Chandrasekharan S; Ganesan R; Muralidharan RS; Mishra AB; Sodhi SS; Rajadhyaksha GC; Jain SD; Kadam GS; Gawde A; Desai A
    J Indian Med Assoc; 2004 Sep; 102(9):525-7. PubMed ID: 15887845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension.
    Frishman WH; Burris JF; Mroczek WJ; Weir MR; Alemayehu D; Simon JS; Chen SY; Bryzinski BS
    J Clin Pharmacol; 1995 Feb; 35(2):182-8. PubMed ID: 7751430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical results with bisoprolol 2.5 mg/hydrochlorothiazide 6.25 mg combination in systolic hypertension in the elderly.
    Benetos A; Adamopoulos C; Argyriadis P; Bean K; Consoli S; Safar M
    J Hypertens Suppl; 2002 Feb; 20(1):S21-5. PubMed ID: 11996196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan with hydrochlorothiazide in the treatment of hypertension.
    Schoenberger JA;
    J Hypertens Suppl; 1995 Jul; 13(1):S43-7. PubMed ID: 18800455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perindopril/hydrochlorothiazide dose combinations for the treatment of hypertension: a multicenter study.
    Chrysant SG
    J Clin Pharmacol; 1997 Jan; 37(1):47-52. PubMed ID: 9048272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new antihypertensive strategy for black patients: low-dose multimechanism therapy.
    Saunders E; Neutel J
    J Natl Med Assoc; 1996 Mar; 88(3):171-5. PubMed ID: 8839032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.